Results 81 to 90 of about 760,766 (138)

Paraurethral Endometrioid Carcinoma Arising From Ectopic Endometriosis: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Malignant transformation of endometriosis is rare and most commonly involves the ovary; transformation from paraurethral endometriosis is exceedingly rare. Case Presentation A 73‐year‐old postmenopausal woman with prior ovarian endometrioma presented with dysuria and voiding difficulty.
Keita Ogasawara   +9 more
wiley   +1 more source

International Radical Cystectomy Consortium: A way forward

open access: yes, 2014
Robot-assisted radical cystectomy (RARC) is an emerging operative alternative to open surgery for the management of invasive bladder cancer. Studies from single institutions provide limited data due to the small number of patients.
Lee Richstone   +73 more
core   +1 more source

Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle‐Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab has emerged as a standard first‐line therapy for advanced urothelial carcinoma (UC). However, pseudoprogression during this combination remains poorly characterized. Case Presentation A 71‐year‐old man with muscle‐invasive bladder cancer and lymph node metastasis received enfortumab vedotin ...
Yosuke Nakanishi   +9 more
wiley   +1 more source

On the Conservativeness of Robust Variance Estimators in Propensity Score Weighted Cox Models

open access: yesPharmaceutical Statistics, Volume 25, Issue 6, November/December 2026.
ABSTRACT In propensity score weighted analysis, robust variance that does not account for weight estimation (hereafter, uncorrected variance) is commonly used. In propensity score weighted Cox models (CoxPSW), the uncorrected variance is known to be conservative when weights for the average treatment effect (ATE) are used, but it remains unclear ...
Hiroya Morita   +3 more
wiley   +1 more source

Robotic assisted radical cystectomy versus open radical cystectomy: a review of what we do and don't know

open access: yes, 2021
Radical cystectomy (RC) is the gold standard treatment for muscle-invasive and high-risk, noninvasive bladder cancer. Since 2003, robot-assisted radical cystectomy (RARC) has been gaining popularity. Metanalyses show that the primary advantage of RARC is
Mehrazin, R   +5 more
core   +1 more source

Urethral Recurrence After Cystectomy and Orthotopic Bladder Reconstruction: A Rare Case of Recurrent Bladder Cancer After 12 Years and Review of the Literature

open access: yesClinical Medicine Insights: Case Reports
Introduction: Radical cystectomy combined with orthotopic urinary diversion is a chosen approach for treating invasive bladder cancer. However, urothelial cell carcinoma is characterized by its potential for recurrence and the development of multiple ...
Trong-Tan Ho Truong   +3 more
doaj   +1 more source

Radical cystectomy and pelvic lymphadenectomy with ileal conduit urinary diversion and abdominal wall reconstruction: an interesting case of multidisciplinary management

open access: yes, 2015
Stratos S Sofos,1 Ciaran Walsh,2 Nigel J Parr,2 Kevin Hancock11Whiston Hospital, Prescot, 2Arrowe Park Hospital, Wirral, Merseyside, UKAbstract: The ileal conduit for urinary diversion after radical cystectomy is a well-described procedure.
Walsh CJ, Sofos SS, Parr NJ, Hancock K
core  

Indirect Comparison of Neoadjuvant Treatment Strategies for Muscle‐Invasive Bladder Cancer: ddMVAC and Perioperative Durvalumab‐Gemcitabine‐Cisplatin Versus Gemcitabine‐Cisplatin: A Systematic Review and Network Meta‐Analysis of Randomised Controlled Trials

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 1962-1973, 15 October 2026.
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold   +12 more
wiley   +1 more source

Perioperative nutrition status of radical cystectomy patients.

open access: yes, 2018
517 Background: Radical cystectomy patients are a vulnerable population, with up to 65% suffering complications and 26% readmitted within 90 days. Patients with aggressive bladder cancer are at high risk for malnutrition. Furthermore, malnutrition is a
Lauren Hand   +6 more
core   +1 more source

Use of MRI in the diagnosis of bladder cancer: a health economic analysis

open access: yes
BJU International, EarlyView.
Niranjan Sathianathen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy